Special Report
-
How to fix Indian pharma's Chinese import problem
Indian pharma's dependence on Chinese imports can be reduced only by developing a domestic ecosystem that boosts and supports drug manufacturers
-
Reinventing Ayurveda for Gen-Z
A bunch of young entrepreneurs is reimagining how the ancient wisdom of ayurveda can be made more palatable for newer generations
-
Laurus Labs: In the big league
Starting out as an API player, Laurus Labs has broadened the scope of its businesses, improving its potential to emerge as a complete pharma company
-
Sensex retraces from 40k levels; uncertain if rally will sustain
The market index rose to a high in early morning trade, but declined sharply in the afternoon, with increased geo-political tensions with China. New investors who came in after the March low might not be ready to experience pain, say experts
-
Even amid the Covid-19 pandemic, top hospitals are losing crores
With patients staying away due to the panic created around contracting the coronavirus, top hospitals are losing big money from postponement of elective surgeries and check-ups
